CHRISTA SLAGLE: Open Payments
NPI 1629478581 · TAMA, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,962 in 127 payments from 20 companies in 2025. Trend: 2023 $1,152 · 2024 $1,780 · 2025 $1,962
Food & beverage: $1,962
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 22 | $399 |
| AstraZeneca Pharmaceuticals LP | 11 | $287 |
| PFIZER INC. | 34 | $269 |
| Amgen Inc. | 19 | $188 |
| Phathom Pharmaceuticals, Inc. | 6 | $180 |
| Lilly USA, LLC | 9 | $166 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $76 |
| Astellas Pharma US Inc | 3 | $53 |
| GlaxoSmithKline, LLC. | 3 | $49 |
| Novo Nordisk Inc | 3 | $49 |
Products named: VRAYLAR, VOQUEZNA, BREZTRI, OTEZLA, NURTEC ODT, JARDIANCE, FARXIGA, MOUNJARO.
Industry payments across IA — which companies pay providers there.
